BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 704429)

  • 1. [Delayed hypersensitivity tests: PPD, DNCB and distreptase in patients with primary lung cancer].
    Słowik-Gabryelska A; Krzyśko R; Menzel-Czapiewska A; Lukaszewicz M; Gizycka D
    Pol Tyg Lek; 1978 Aug; 33(33):1299-302. PubMed ID: 704429
    [No Abstract]   [Full Text] [Related]  

  • 2. [Skin tests of delayed hypersensitivity (tuberculin, DNCB) in the immunologic study of patients with primary cancer of the lung].
    Bariffi F; Illiano A; Tranfa CM; Del Prato B
    Arch Monaldi; 1978; 33(4):239-50. PubMed ID: 756707
    [No Abstract]   [Full Text] [Related]  

  • 3. [Delayed hypersensitivity response of the skin to 2,4-dinitrochlorobenzene and old tuberculin in patients with lung cancer].
    Fan XJ
    Zhonghua Zhong Liu Za Zhi; 1983 Sep; 5(5):333-6. PubMed ID: 6653356
    [No Abstract]   [Full Text] [Related]  

  • 4. [Prognostic value of skin tests with tuberculin, distreptase and dinitrochlorobenzene in primary lung cancer].
    Słowik-Gabryelska A; Krzyśko R; Menzel-Czapiewska A
    Pneumonol Pol; 1979 Apr; 47(4):257-63. PubMed ID: 450735
    [No Abstract]   [Full Text] [Related]  

  • 5. Sequential evaluation of DNCB reactivity in patients with primary lung cancer. Correlation with prognosis.
    Inoue H; Ishihara T; Kobayashi K; Fukai S
    J Thorac Cardiovasc Surg; 1978 Oct; 76(4):479-82. PubMed ID: 703354
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Delayed hypersensitivity intracutaneous test with dinitrochlorobenzene (DNCB)].
    Grigorovich NA; Martysiuk TI; Monastyrnaia PL
    Vopr Onkol; 1979; 25(7):94-5. PubMed ID: 483690
    [No Abstract]   [Full Text] [Related]  

  • 7. [The DNCB test in pneumology].
    Polistina D
    Arch Monaldi; 1977; 32(3):15-8. PubMed ID: 616268
    [No Abstract]   [Full Text] [Related]  

  • 8. Prognostic significance of skin reactivity in patients with bronchogenic carcinoma grouped according to the TNM classification.
    Plesnicar S; Rudolf Z; Lavrencic D
    Neoplasma; 1977; 24(6):633-40. PubMed ID: 593468
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Qualitative DNCB skin test in cancer patients.
    Dutta TK; Sengputa U; Gupta BD
    Indian J Cancer; 1977 Dec; 14(4):351-3. PubMed ID: 612559
    [No Abstract]   [Full Text] [Related]  

  • 10. [Delayed immunity in bronchial cancer: lymphocyte activation in culture with phytohemagglutinins and tuberculin PPD compared with the skin response to tubercular antigens].
    Piacentini G; Ferrari S; Megale C; Ippoliti F
    Boll Ist Sieroter Milan; 1973; 52(3):230-6. PubMed ID: 4762779
    [No Abstract]   [Full Text] [Related]  

  • 11. [Role of immune skin reactions in progressive lung cancer during the administration of OK-432--relation to reactions to DNCB, PPD and Su-PS].
    Katada H; Nishikawa K; Yoneda T; Kitamura H; Nakajima A; Mikami R
    Gan To Kagaku Ryoho; 1987 Jan; 14(1):61-70. PubMed ID: 3026256
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Behavior of DNCB and tuberculin skin tests in relation to the various histological types of pulmonary cancer].
    Soresi V; Invernizzi G; Schiraldi G; Borghini U; Sacerdoti C; Maruzzi M
    Boll Ist Sieroter Milan; 1981 Jul; 60(3):216-21. PubMed ID: 6275868
    [No Abstract]   [Full Text] [Related]  

  • 13. [Study of delayed hypersensitivity in patients with cutaneous tuberculosis by the in vivo and in vitro methods].
    Arkuszewska C; Olszewska Z; Płuzańska A
    Przegl Dermatol; 1980; 67(1):31-6. PubMed ID: 7375651
    [No Abstract]   [Full Text] [Related]  

  • 14. [Delayed hypersensitivity in pediatric patients with cancer].
    Rivera Luna R; Munford DM; Wilbur JR
    Bol Med Hosp Infant Mex; 1977; 34(6):11-71. PubMed ID: 588329
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A technique for intensifying BCG sensitivity.
    Parmett SR; Klein E
    J Med; 1975; 6(3-4):213-6. PubMed ID: 1104733
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Methyl heptine carbonate skin test in lung cancer--correlation with stage and prognosis].
    Takanami I; Nakayama H; Ishihara T; Yanai N
    Gan No Rinsho; 1984 Apr; 30(4):340-3. PubMed ID: 6727035
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Correlations between DNCB skin hypersensitivity and leukocyte migration inhibition by DNCB-coated human erythrocytes.
    Walewski J; Nowakowska A
    Arch Immunol Ther Exp (Warsz); 1981; 29(1):29-33. PubMed ID: 7283677
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Skin tests as immunologic parameters in cervical cancer].
    Wagner G
    Wien Klin Wochenschr; 1984 Jun; 96(12):467-73. PubMed ID: 6475075
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunologic defects in lung cancer patients.
    Holmes EC; Golub SH
    J Thorac Cardiovasc Surg; 1976 Feb; 71(2):161-8. PubMed ID: 1107678
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impaired cell-mediated immunity in patients with kala-azar.
    Hepner Levy L; Mendes E
    Allergol Immunopathol (Madr); 1981; 9(2):109-12. PubMed ID: 7293874
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.